These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16920751)

  • 41. Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
    Huscher D; Pittrow D; Distler O; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Kowal-Bielecka O; Avouac J; Behrens F; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE;
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S47-52. PubMed ID: 20576214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Progressive systemic sclerosis].
    Tokano Y; Hirose S
    Ryoikibetsu Shokogun Shirizu; 1994; (4):537-9. PubMed ID: 8007234
    [No Abstract]   [Full Text] [Related]  

  • 43. Screening for pulmonary arterial hypertension in systemic sclerosis.
    Busteed S; Moots RJ; Thompson RN
    Rheumatology (Oxford); 2004 Oct; 43(10):1315-6; author reply 1316. PubMed ID: 15448224
    [No Abstract]   [Full Text] [Related]  

  • 44. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
    Fischer A; Bull TM; Steen VD
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed hypersensitivity to bosentan.
    Romano A; Giovannetti A; Caruso C; Rosato E; Pierdominici M; Salsano F
    Allergy; 2009 Mar; 64(3):499-501. PubMed ID: 19220223
    [No Abstract]   [Full Text] [Related]  

  • 47. Borderline pulmonary pressures in scleroderma - a 'pre-pulmonary arterial hypertension' condition?
    Kovacs G; Olschewski H
    Arthritis Res Ther; 2015 May; 17(1):123. PubMed ID: 25981512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?
    Pamidi S; Mehta S
    J Rheumatol; 2009 Feb; 36(2):216-8. PubMed ID: 19208554
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic sclerosis - continuing progress in developing clinical measures of response.
    Furst D; Khanna D; Matucci-Cerinic M; Clements P; Steen V; Pope J; Merkel P; Foeldvari I; Seibold J; Pittrow D; Polisson R; Strand V
    J Rheumatol; 2007 May; 34(5):1194-200. PubMed ID: 17477486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ["Pulmonary hypertension" of the gastrointestinal tract in patients with systemic sclerosis: thoughts on a not (yet) existing disease entity].
    Müller-Ladner U
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S203-5. PubMed ID: 18814097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cicletanine for the treatment of pulmonary arterial hypertension.
    Waxman AB; Lawler L; Cornett G
    Arch Intern Med; 2008 Oct; 168(19):2164-6. PubMed ID: 18955648
    [No Abstract]   [Full Text] [Related]  

  • 52. Tadalafil (Adcirca) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245
    [No Abstract]   [Full Text] [Related]  

  • 53. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis.
    Ocken S; Reinitz E; Strom J
    Arthritis Rheum; 1983 Jun; 26(6):794-6. PubMed ID: 6860381
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM; Stevens WM; Sahhar J; Celermajer D
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New frontiers in pulmonary hypertension.
    Rubin LJ; Morrell NW
    Expert Rev Respir Med; 2011 Apr; 5(2):139-40. PubMed ID: 21510723
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary hypertension.
    Tektonidou M
    N Engl J Med; 2005 Jan; 352(4):418-9; author reply 418-9. PubMed ID: 15675104
    [No Abstract]   [Full Text] [Related]  

  • 59. The CREST syndrome--successful reduction of pulmonary hypertension by captopril.
    Prouse PJ; Lahiri A; Gumpel JM
    Postgrad Med J; 1984 Oct; 60(708):672-4. PubMed ID: 6387690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Campo A; Mathai SC; Girgis RE; Hassoun PM
    Chest; 2010 Aug; 138(2):461-2; author reply 462-3. PubMed ID: 20682545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.